• Ayush Sanjivani mobile app developed by Ministry of AYUSH has also been launched to generate data on acceptance and usage of AYUSH advocacies and measures among the population and its impact in prevention of COVID-19 targeting 05 million population. 
  • Ministry of AYUSH issued public advisories of Ayush-based healthcare during COVID-19 outbreak and promulgated a generic formulation called Ayush Kwath/Ayush Kudineer/Ayush Joshanda. 
  • As per the provisions of Drugs & Cosmetics Act, 1940 and Rules there under, approval of Ministry of AYUSH is not required to manufacture for sale of Ayurvedic, Siddha and Unani drugs and such medicinal formulations. 
  • Powers of regulation and quality control of these drugs and formulations are vested with the State Governments, for which State Licensing Authorities/Drug Controllers are appointed.